Becton Dickinson & Co.

BDX ·Healthcare, Medical Devices, United States

Net Cash Flow Breakdown

FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008 FY2007

Total Cash from Operations: $1.86B

Line Item	Value	% of Total
Capital Expenditures	$592.0M	31.8%
Business Acquisitions	$40.0M	2.2%
Other Investing	$301.6M	16.2%
Dividends Paid	$414.6M	22.3%
Stock Repurchases	$393.9M	21.2%
Net Change in Short-Term Borrowings	$3.9M	0.2%
Working Capital	$114.0M	6.1%
Net Cash Flow	$0	0.0%